ProQR Therapeutics N.V.
PRQR · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $209 | $145 | $248 | $452 |
| - Cash | $149 | $119 | $95 | $188 |
| + Debt | $17 | $20 | $22 | $60 |
| Enterprise Value | $77 | $46 | $175 | $325 |
| Revenue | $19 | $7 | $4 | $1 |
| % Growth | 190.2% | 81.2% | 169.2% | – |
| Gross Profit | $19 | $7 | $4 | $1 |
| % Margin | 100% | 100% | 100% | 100% |
| EBITDA | -$24 | -$24 | -$56 | -$55 |
| % Margin | -127.6% | -369.9% | -1,571% | -4,116% |
| Net Income | -$28 | -$28 | -$64 | -$61 |
| % Margin | -146.9% | -431.7% | -1,792.5% | -4,549.8% |
| EPS Diluted | -0.34 | -0.35 | -0.91 | -0.96 |
| % Growth | 2.9% | 61.5% | 5.2% | – |
| Operating Cash Flow | -$36 | $22 | -$69 | -$26 |
| Capital Expenditures | -$1 | -$1 | -$1 | -$0 |
| Free Cash Flow | -$38 | $20 | -$69 | -$26 |